March 2010 Issue of MMM
Just a few hours before a heavy blizzard almost brought last month's ePharma Summit to its knees, a man called Dave deBronkart, aka e-Patient Dave, ...
Pharma companies and their partners are under pressure to evolve the marketing research function through new technology and fresh thinking
New developments in specialty pharma are changing the way manufacturers, payers, docs and patients interact. Ben Comer looks at where things are headed
Deep analysis of the provider-patient dialogue can give brand-name drugs an edge in the marketplace. Jeff Kozloff and David Franke looks at how this dialogue ...
Hundreds of healthcare advertising and publishing leaders braved the storm and gathered at at New York's Pierre Hotel to honor the 2010 Medical Advertising Hall ...
In January 2007 Dave deBronkart, aka e-Patient Dave, was diagnosed with stage IV kidney cancer that had spread throughout his body and given a median ...
For years, healthcare marketing research has begun with a proposal and ended with a final report containing "conclusions" and "recommendations."
The film Extraordinary Measures, just released, details the discovery of a replacement enzyme for the neuromuscular disorder Pompe disease.
It was activism that drew the world's attention to the HIV epidemic and to the need for ethical standards in AIDS-drug testing. And activism is ...
Novartis' US sales reorganization seems to have paid off in 2009 as the company held the line on sales and marketing expenses despite a passel ...
UK regulators vowed to investigate a medical journal ad for AstraZeneca's Seroquel that allegedly minimized weight gain data, a common side effect associated with atypical ...
Featuring news about GlaxoSmithKline and Merck
Med Ed Report
In the last 12 months, 142 medical-education providers either lost their accreditation to offer CME or decided not to apply for renewal, said the ACCME ...
An analysis of CME data by two Cleveland Clinic Foundation physicians found little evidence of perceived bias in CME activities.
CME firm Pri-Med Institute has changed its name to pmiCME, a name which more clearly distinguishes it as an accredited provider, the company said last ...
Featuring news about Cephalon, the AMA and the ACCME
Healthy Advice Networks is betting doctors need one more video screen to look at during office hours.
Sermo has nixed its financial services offering, cutting headcount sharply as a result, and is doubling down on its pharma business.
Featuring news about Nature Publishing, Slack Inc. and Elsevier
Integrating journal ads into a media schedule was a challenge before professional media entered a period of contraction. With ad budgets shrinking and use of ...
Social media marketers should make it easy for consumers to consider the source when products are being discussed, according to new disclosure guidelines from the ...
Pfizer said it will partner with Keas, a developer of online health organizers, to "enable health and wellness experts to author, sell and distribute personalized ...
Featuring news about Everyday Health, WebMD, Medscape, Ascend Integrated Media, Mobilco, comScore and ARSgroup
Having been born in 1997, DTC advertising is now officially a "teenager." And just like any teen, it has its moments of rebellion (getting ready ...
AstraZeneca is answering OTC Prevacid with ads touting Nexium's nighttime benefits.
Boehringer Ingelheim is sponsoring a star-studded COPD awareness effort with NASCAR, the American Lung Association and the COPD Foundation.
Medtronic launched a video contest aimed at diabetic kids, who use an insulin pump, and their parents.
If there was any doubt, online health video has officially arrived as a means of reaching consumers.
Featuring news about GlaxoSmithKline, Lundbeck, National Organization for Rare Disorders, Campaign magazine and Pfizer
The Minnesota pharmacy board maintained that it's legal to pay doctors to answer bona fide marketing surveys, but legislation being debated may keep the state ...
Bayer announced that it will split global advertising duties between Omnicom and WPP, a consolidation process set to be completed over the next two years.
The compassion and goodwill of the medical advertising agency community has turned what started as a single donation to the Haitian earthquake relief effort into ...
Featuring news about GCI Health, Roska Healthcare Advertising, Heartbeat Digital and Draftfcb Healthcare
"Podium policy" (when regulators give speeches or interviews that announce new regulatory expectations) is never a good idea.
A week after promising non-military government austerity in his State of the Union address, President Obama proposes a second successive record annual hike in FDA ...
In an adverse finding on an appeal by Purdue Pharma executives over OxyContin marketing, an HHS Departmental Appeals Board says that corporate officials can be ...
Funny what gets people's attention. Today's topic du jour is social media—every pharma company sports an ad hoc committee, umpteen hyperbolic stories in the press, ...
Social media continues to be something of a blind spot for the pharma and medical device industries, with only a tiny fraction of all marketing ...
Call it the law of unintended consequences or the perfect storm or a bad hair day or any other cliché you can think of, but ...
- McCann Health forms new global consultancy
- Alexion uses superheroes, social media to raise rare-disease awareness
- Five things for pharma marketers to know: Tuesday, September 20, 2016
- Five things for pharma marketers to know: Wednesday, September 21, 2016
- Five things for pharma marketers to know: Monday, September 19, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- When it comes to professional ads, print makes its comeback
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- The FDA approves Amgen's biosimilar version of Humira
- Five things for pharma marketers to know: Friday, September 23, 2016
- Five things for pharma marketers to know: Thursday, September 22, 2016
- Drug Pricing Will Be a Key Issue, Whether Clinton or Trump Win the Election
- The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study